US Patent Issued to Zensun (Shanghai) Science & Technology on June 9 for "Recombinant human neuregulin derivatives and use thereof" (Chinese Inventor)

ALEXANDRIA, Va., June 9 -- United States Patent no. 12,649,769, issued on June 9, was assigned to Zensun (Shanghai) Science & Technology Co. Ltd. (Shanghai).

"Recombinant human neuregulin derivatives and use thereof" was invented by Mingdong Zhou (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is a use of recombinant human neuregulin derivatives in preparing a medicine for preventing, treating, or reducing the progression of cardiovascular diseases in mammals. In particular, the present invention relates to a novel recombinant human NRG-FC protein and a use thereof in the treatment of cardiovascular diseases. The protein has a prolonged half-life and enhanced biological activity."

The pat...